Primmune Therapeutics
Primmune Therapeutics is a Biotechnology company.
Launch date
Employees
Market cap
-
Enterprise valuation
€31—46m (Dealroom.co estimates Nov 2021.)
San Diego California (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
N/A | $1.5m | Seed | |
* | $7.0m | Seed | |
$27.4m | Series A | ||
$4.0m | Series A | ||
N/A | $8.4m | Series A | |
Total Funding | €43.9m |
Related Content
Recent News about Primmune Therapeutics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.